echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Pfizer acquires InnoPharma, an injection product maker, for US$360 million

    Pfizer acquires InnoPharma, an injection product maker, for US$360 million

    • Last Update: 2014-07-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: wisdom 2014-07-18 Pfizer announced on Wednesday that it will purchase innopharma, a US sterile injection product manufacturer, for no more than US $360 million According to the agreement, Pfizer will purchase innopharma for us $225 million in cash, and after the latter reaches an important goal, continue to pay US $135 million, not more than US $360 million in total The acquisition will be completed in the third quarter of 2014 Innopharma was founded in 2005 Its main business is various injections and plans to expand its business to oral suspension and nasal aspirates At present, the company has 10 listed products, 30 products under research, and 19 products are applying to the U.S Food and Drug Administration (FDA) for approval.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.